搜尋結果
2022
Huang, Y. M. ,
Wei, P. L. ,
Ho, C. H. &
Yeh, C. C. ,
2月 2 2022 ,
於: Journal of Clinical Medicine. 11 ,
4 , 913.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Cigarette Smoking
100%
Colorectal Neoplasms
80%
Cohort Studies
68%
Survival
55%
Population
39%
Kamiza, A. B. ,
Fatumo, S. ,
Singini, M. G. ,
Yeh, C. C. &
Chikowore, T. ,
5月 2022 ,
於: EBioMedicine. 79 , 104003.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chronic Hepatitis B
100%
Random Allocation
91%
Hepatitis B
90%
Infections
44%
Neoplasms
30%
Yu, M. Z. ,
Wu, M. M. ,
Chien, H. T. ,
Liao, C. T. ,
Su, M. J. ,
Huang, S. F. &
Yeh, C. C. ,
11月 2022 ,
於: Cancers. 14 ,
21 , 5338.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Head and Neck Neoplasms
100%
Population
38%
Areca
29%
Mastication
22%
Cigarette Smoking
19%
Liao, L. N. ,
Li, T. C. ,
Yeh, C. C. ,
Li, C. I. ,
Liu, C. S. ,
Yang, C. W. ,
Yang, Y. F. ,
Lin, C. H. ,
Tsai, F. J. &
Lin, C. C. ,
2022 , (接受/付印)
於: Acta Diabetologica. 60 ,
3 ,
p. 413-424 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Diabetic Nephropathies
100%
Type 2 Diabetes Mellitus
70%
Single Nucleotide Polymorphism
63%
Taiwan
37%
Risk Management
20%
Huang, E. J. C. ,
Sung, F. C. ,
Hung, P. H. ,
Muo, C. H. ,
Wu, M. M. &
Yeh, C. C. ,
9月 2022 ,
於: International journal of molecular sciences. 23 ,
17 , 9634.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Erythropoietin
100%
degeneration
89%
Macular Degeneration
73%
Renal Dialysis
61%
Cohort Studies
47%
2021
Wu, C. M. ,
Su, F. H. ,
Muo, C. H. ,
Huang, J. C. ,
Wu, M. M. &
Yeh, C. C. ,
3月 14 2021 ,
於: Viruses. 13 ,
3 , 475.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Ribavirin
100%
Chronic Hepatitis C
92%
Hepacivirus
82%
Interferons
81%
Virus Diseases
65%
Wang, W. C. ,
Lin, Y. S. ,
Chang, Y. F. ,
Yeh, C. C. ,
Su, C. T. ,
Wu, J. S. &
Su, F. H. ,
8月 18 2021 ,
於: Frontiers in Immunology. 12 , 710414.
研究成果: 雜誌貢獻 › 文章 › 同行評審
HLA Antigens
100%
Hepatitis B virus
94%
Young Adult
78%
Vaccination
77%
Newborn Infant
74%
Senghore, T. ,
Wang, W. C. ,
Chien, H. T. ,
Chen, Y. X. ,
Young, C. K. ,
Huang, S. F. &
Yeh, C. C. ,
2月 2021 ,
於: Gene. 768 ,
p. 145283 145283.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chemoradiotherapy
100%
Squamous Cell Carcinoma
78%
Survival
51%
Double-Stranded DNA Breaks
35%
Genotype
22%
Kamiza, A. B. ,
Wang, W. C. ,
You, J. F. ,
Tang, R. ,
Chien, H. T. ,
Lai, C. H. ,
Chiu, L. L. ,
Lo, T. P. ,
Hung, K. Y. ,
Hsiung, C. A. &
Yeh, C. C. ,
4月 26 2021 ,
於: Scientific Reports. 11 ,
1 ,
p. 8899 1 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hereditary Nonpolyposis Colorectal Neoplasms
100%
Taiwan
75%
Colorectal Neoplasms
60%
Mutation
35%
Confidence Intervals
30%
Hung, P. H. ,
Yeh, C. C. ,
Hsiao, C. Y. ,
Muo, C. H. ,
Hung, K. Y. &
Tsai, K. J. ,
7月 20 2021 ,
於: Journal of the American Heart Association. 10 ,
14 , e019529.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Erythropoietin
100%
Taiwan
94%
Renal Dialysis
82%
Stroke
65%
Cohort Studies
64%
Yeh, C. C. ,
Wu, M. M. ,
Wu, C. M. ,
Sung, F. C. ,
Muo, C. H. ,
Te, A. &
Su, F. H. ,
4月 28 2021 ,
於: Viruses. 13 ,
5 , 790.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Propensity Score
100%
Chronic Hepatitis C
97%
Macular Degeneration
97%
Taiwan
92%
Hepacivirus
86%
Su, F. H. ,
Bai, C. H. ,
Le, T. N. ,
Muo, C. H. ,
Chang, S. N. ,
Te, A. ,
Sung, F. C. &
Yeh, C. C. ,
1月 8 2021 ,
於: Frontiers in Oncology. 10 , 561420.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chronic Hepatitis C
100%
Taiwan
94%
Hepacivirus
88%
Case-Control Studies
76%
Colorectal Neoplasms
75%
Chien, H. T. ,
Yeh, C. C. ,
Young, C. K. ,
Chen, T. P. ,
Liao, C. T. ,
Wang, H. M. ,
Cho, K. L. &
Huang, S. F. ,
5月 2021 ,
於: Journal of Personalized Medicine. 11 ,
5 , 425.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Mouth Neoplasms
100%
Neoplasms
29%
Head and Neck Neoplasms
22%
Alcohol Drinking
20%
Esophagoscopes
20%
2020
Su, F. H. ,
Le, T. N. ,
Muo, C. H. ,
Te, S. A. ,
Sung, F. C. &
Yeh, C. C. ,
1月 1 2020 ,
於: Viruses. 12 ,
1 , 97.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chronic Hepatitis B
100%
Colorectal Neoplasms
74%
Population
36%
Hepatitis B
30%
Taiwan
20%
Senghore, T. ,
Chien, H. T. ,
Wang, W. C. ,
Chen, Y. X. ,
Young, C. K. ,
Huang, S. F. &
Yeh, C. C. ,
12月 2020 ,
於: Pharmacogenomics Journal. 20 ,
6 ,
p. 813-822 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Adjuvant Chemoradiotherapy
100%
Chemoradiotherapy
71%
Squamous Cell Carcinoma
55%
Genotype
47%
Disease-Free Survival
20%
2019
Wu, C. M. ,
Su, F. H. ,
Wang, W. C. ,
Lin, C. P. ,
Kamiza, A. B. ,
Chang, S. N. &
Yeh, C. C. ,
8月 2019 ,
於: Acta Ophthalmologica. 97 ,
5 ,
p. e713-e718 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chronic Hepatitis B
100%
Macular Degeneration
97%
Cercopithecine Herpesvirus 1
47%
Hepatitis B virus
45%
National Health Programs
24%
Hung, P. H. ,
Yeh, C. C. ,
Sung, F. C. ,
Hsiao, C. Y. ,
Muo, C. H. ,
Hung, K. Y. &
Tsai, K. J. ,
9月 1 2019 ,
於: Aging. 11 ,
17 ,
p. 6941-6950 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Erythropoietin
100%
Renal Dialysis
82%
Dementia
79%
Population
37%
Chronic Kidney Failure
27%
Senghore, T. ,
Chien, H-T. ,
Wang, W-C. ,
Chen, Y-X. ,
Young, C-K. ,
Huang, S-F. &
Yeh, C-C. ,
1月 1 2019 ,
於: Journal of Clinical Medicine. 8 ,
1 ,
p. 33 研究成果: 雜誌貢獻 › 文章 › 同行評審
Adjuvant Chemoradiotherapy
100%
Chemoradiotherapy
71%
DNA Repair
61%
Squamous Cell Carcinoma
55%
Genotype
47%
Senghore, T. ,
Wang, W-C. ,
Chien, H-T. ,
Chen, Y-X. ,
Young, C-K. ,
Huang, S-F. &
Yeh, C-C. ,
4月 29 2019 ,
於: Cancers. 11 ,
5 研究成果: 雜誌貢獻 › 文章 › 同行評審
Adjuvant Chemoradiotherapy
100%
MutS Proteins
80%
DNA Mismatch Repair
79%
Chemoradiotherapy
71%
Squamous Cell Carcinoma
55%
2018
Lin, Y. S. ,
Yeh, C. C. ,
Huang, S. F. ,
Chou, Y. S. ,
Kuo, L. T. ,
Sung, F. C. ,
Muo, C. H. ,
Su, C. T. &
Su, F. H. ,
8月 1 2018 ,
於: PLoS One. 13 ,
8 , e0199014.
研究成果: 雜誌貢獻 › 文章 › 同行評審
head and neck neoplasms
100%
risk reduction
70%
aspirin
66%
Risk Reduction Behavior
56%
Head and Neck Neoplasms
55%
glutathione peroxidase GPX1
100%
Superoxide
64%
Catalase
63%
Superoxide Dismutase
60%
Glutathione
58%
Senghore, T. ,
Li, Y-F. ,
Sung, F-C. ,
Tsai, M-H. ,
Hua, C-H. ,
Liu, C-S. ,
Hung, M-F. &
Yeh, C-C. ,
2018 ,
於: Anticancer Research. 38 ,
7 ,
p. 4021-4026 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Methylenetetrahydrofolate Reductase (NADPH2)
100%
Haplotypes
54%
Genotype
41%
Alleles
28%
Odds Ratio
24%
Senghore, T. ,
Li, Y-F. ,
Sung, F-C. ,
Tsai, M-H. ,
Hua, C-H. ,
Liu, C-S. ,
Huang, R-J. &
Yeh, C-C. ,
2018 ,
於: Anticancer Research. 38 ,
9 ,
p. 5211-5216 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
8-epi-prostaglandin F2alpha
100%
Leukoplakia
64%
Oxidative Stress
51%
Biomarkers
45%
Odds Ratio
30%
Kamiza, A. B. ,
Wang, W. C. ,
You, J. F. ,
Tang, R. ,
Wang, Y. T. ,
Chien, H. T. ,
Lai, C. H. ,
Chiu, L. L. ,
Lo, T. P. ,
Hung, K. Y. ,
Hsiung, C. A. &
Yeh, C. C. ,
10月 1 2018 ,
於: Anticancer Research. 38 ,
10 ,
p. 5983-5990 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Transforming Growth Factor-beta Type II Receptors
100%
Hereditary Nonpolyposis Colorectal Neoplasms
92%
ErbB Receptors
67%
Colorectal Neoplasms
55%
Genotype
36%
Hung, C. L. ,
Yeh, C. C. ,
Sung, P. S. ,
Hung, C. J. ,
Muo, C. H. ,
Sung, F. C. ,
Jou, I. M. &
Tsai, K. J. ,
9月 1 2018 ,
於: World Journal of Surgery. 42 ,
9 ,
p. 2864-2871 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Thyroidectomy
100%
Osteoporosis
81%
Osteoporotic Fractures
54%
Population
35%
Thyroxine
18%
Kamiza, A. B. ,
Hsieh, L. L. ,
Tang, R. ,
Chien, H. T. ,
Lai, C. H. ,
Chiu, L. L. ,
Lo, T. P. ,
Hung, K. Y. ,
You, J. F. ,
Wang, W. C. ,
Hsiung, C. A. &
Yeh, C. C. ,
7月 1 2018 ,
於: Molecular Genetics and Genomic Medicine. 6 ,
4 ,
p. 533-540 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hereditary Nonpolyposis Colorectal Neoplasms
100%
DNA Repair
70%
Colorectal Neoplasms
60%
Confidence Intervals
36%
Genes
30%
Kamiza, A. B. ,
You, J. F. ,
Wang, W. C. ,
Tang, R. ,
Chang, C. Y. ,
Chien, H. T. ,
Lai, C. H. ,
Chiu, L. L. ,
Lo, T. P. ,
Hung, K. Y. ,
Hsiung, C. A. &
Yeh, C. C. ,
2018 ,
於: Environmental and Molecular Mutagenesis. 59 ,
1 ,
p. 69-78 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hereditary Nonpolyposis Colorectal Neoplasms
100%
Xenobiotics
83%
Taiwan
75%
Nucleotide
62%
Meat
62%
Hu, Y. C. ,
Yeh, C. C. ,
Chen, R. Y. ,
Su, C. T. ,
Wang, W. C. ,
Bai, C. H. ,
Chan, C. F. &
Su, F. H. ,
2018 ,
於: PeerJ. 2018 ,
2 , e4297.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Hepatitis B virus
100%
Seroepidemiologic Studies
79%
seroprevalence
76%
Taiwan
71%
vaccination
64%
Yeh, C. C. ,
Su, F. H. ,
Tzeng, C. R. ,
Muo, C. H. &
Wang, W. C. ,
3月 2018 ,
於: PLoS ONE. 13 ,
3 , e0194011.
研究成果: 雜誌貢獻 › 文章 › 同行評審
thyroid neoplasms
100%
Adenomyosis
84%
cohort studies
83%
Thyroid
76%
Endometrial Neoplasms
62%
2017
Lai, G. L. ,
Yeh, C. C. ,
Yeh, C. Y. ,
Chen, R. Y. ,
Fu, C. L. ,
Chen, C. H. &
Tzeng, C. R. ,
12月 1 2017 ,
於: Reproductive Toxicology. 74 ,
p. 77-84 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Trace Metal
100%
Endometriosis
94%
Zinc
85%
Inductively Coupled Plasm Mass Spectrometry (ICPMS)
44%
Superoxide
43%
Hung, P. H. ,
Yeh, C. C. ,
Hsiao, C. Y. ,
Sung, P. S. ,
Muo, C. H. ,
Sung, F. C. ,
Hung, K. Y. &
Tsai, K. J. ,
1月 1 2017 ,
於: Oncotarget. 8 ,
64 ,
p. 107348-107355 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Peritoneal Dialysis
100%
Chronic Kidney Failure
97%
Dementia
92%
Renal Dialysis
80%
Alzheimer Disease
28%
Yeh, C. C. ,
Goyal, A. ,
Shen, J. ,
Wu, H. C. ,
Strauss, J. A. ,
Wang, Q. ,
Gurvich, I. ,
Safyan, R. A. ,
Manji, G. A. ,
Gamble, M. V. ,
Siegel, A. B. &
Santella, R. M. ,
11月 1 2017 ,
於: Annals of Surgical Oncology. 24 ,
12 ,
p. 1-8 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
DNA Methylation
100%
Methylation
91%
Folic Acid
89%
Hepatocellular Carcinoma
81%
Survival
56%
Sung, P. S. ,
Yeh, C. C. ,
Wang, L. C. ,
Hung, P. H. ,
Muo, C. H. ,
Sung, F. C. ,
Chen, C. H. &
Tsai, K. J. ,
3月 1 2017 ,
於: Current Alzheimer Research. 14 ,
3 ,
p. 309-316 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Sleep Wake Disorders
100%
Dementia
76%
Cognitive Dysfunction
20%
Sleep Apnea Syndromes
8%
Propensity Score
8%
Lin, Y. S. ,
Yeh, C. C. ,
Lin, Y. C. ,
Su, C. T. ,
Sung, F. C. ,
Chang, S. N. ,
Liu, Y. R. &
Su, F. H. ,
1月 1 2017 ,
於: American Journal of Nephrology. 45 ,
1 ,
p. 22-31 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Kidney Neoplasms
100%
Chronic Hepatitis
95%
Hepatitis B virus
38%
Hepacivirus
36%
Virus Diseases
36%
Yeh, C. C. ,
Lai, C. Y. ,
Chang, S. N. ,
Hsieh, L. L. ,
Tang, R. ,
Sung, F. C. &
Lin, Y. K. ,
6月 1 2017 ,
於: International Journal of Clinical Oncology. 22 ,
3 ,
p. 483-493 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Methylenetetrahydrofolate Reductase (NADPH2)
100%
Fluorouracil
74%
Colorectal Neoplasms
61%
Drug Therapy
45%
Survival
42%
Lin, Y. K. ,
Huang, C. F. ,
Liao, Y. C. &
Yeh, C. C. ,
4月 3 2017 ,
於: International Journal of Production Research. 55 ,
7 ,
p. 1957-1969 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
System Reliability
100%
Time Windows
88%
Delivery Time
81%
Container
75%
Containers
68%
2016
Su, F. H. ,
Huang, Y. L. ,
Sung, F. C. ,
Su, C. T. ,
Hsu, W. H. ,
Chang, S. N. &
Yeh, C. C. ,
1月 2 2016 ,
於: Vaccine. 34 ,
1 ,
p. 120-127 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
chronic hepatitis B
100%
HBV
96%
influenza vaccination
91%
Hepatitis B virus
74%
vaccination
59%
Lai, C-Y. ,
Hsieh, L-L. ,
Tang, R. ,
Santella, R. M. ,
Chang-Chieh, C. R. &
Yeh, C-C. ,
3月 28 2016 ,
於: World Journal of Gastroenterology. 22 ,
12 ,
p. 3372-80 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Taiwan
100%
Colorectal Neoplasms
80%
Haplotypes
27%
Alleles
21%
Genotype
20%
Yeh, C. C. ,
Wang, W. C. ,
Wu, C. S. ,
Sung, F. C. ,
Su, C. T. ,
Shieh, Y. H. ,
Chang, S. N. &
Su, F. H. ,
8月 1 2016 ,
於: PLoS One. 11 ,
8 , e0161958.
研究成果: 雜誌貢獻 › 文章 › 同行評審
chronic hepatitis
100%
Hepatitis C virus
72%
Hepatitis Viruses
72%
odds ratio
71%
confidence interval
61%
Kamiza, A. B. ,
Su, F. H. ,
Wang, W. C. ,
Sung, F. C. ,
Chang, S. N. &
Yeh, C. C. ,
11月 8 2016 ,
於: BMC Cancer. 16 ,
1 , 861.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Chronic Hepatitis
100%
Taiwan
92%
Confidence Intervals
55%
Infections
44%
Population
36%
Shen, J. ,
Yeh, C. C. ,
Wang, Q. ,
Gurvich, I. ,
Siegel, A. B. &
Santella, R. M. ,
10月 1 2016 ,
於: Anticancer Research. 36 ,
10 ,
p. 5307-5314 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Adiponectin
100%
Liver Transplantation
84%
Hepatocellular Carcinoma
74%
Leptin
57%
Survival
51%
Kamiza, A. B. ,
Hsieh, L. L. ,
Tang, R. ,
Chien, H. T. ,
Lai, C. H. ,
Chiu, L. L. ,
Lo, T. P. ,
Hung, K. Y. ,
You, J. F. ,
Wang, W. C. ,
Hsiung, C. A. &
Yeh, C. C. ,
12月 1 2016 ,
於: PLoS One. 11 ,
12 , e0167354.
研究成果: 雜誌貢獻 › 文章 › 同行評審
cohort studies
100%
Hereditary Nonpolyposis Colorectal Neoplasms
95%
colorectal neoplasms
89%
Taiwan
72%
confidence interval
62%
2015
Kamiza, A. B. ,
Hsieh, L. L. ,
Tang, R. ,
Chien, H. T. ,
Lai, C. H. ,
Chiu, L. L. ,
Lo, T. P. ,
Hung, K. Y. ,
Wang, C. Y. ,
You, J. F. ,
Hsiung, C. A. &
Yeh, C. C. ,
6月 8 2015 ,
於: PLoS ONE. 10 ,
6 , e0130018.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Lynch Syndrome II
100%
Taiwan
52%
Colorectal Neoplasms
42%
Germ-Line Mutation
36%
Mutation
29%
2014
Lu, K. ,
Wang, H. K. ,
Yeh, C. C. ,
Huang, C. Y. ,
Sung, P. S. ,
Wang, L. C. ,
Muo, C. H. ,
Sung, F. C. ,
Chen, H. J. ,
Li, Y. C. ,
Chang, L. C. &
Tsai, K. J. ,
2014 ,
於: BioMed Research International. 2014 , 861812.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Rheumatic Diseases
100%
Autoimmune Diseases
81%
Dementia
78%
Health Insurance
10%
Ambulatory Care
10%
Su, F-H. ,
Wu, C. S. ,
Sung, F. C. ,
Chang, S. N. ,
Su, C-T. ,
Shieh, Y-H. &
Yeh, C-C. ,
11月 21 2014 ,
於: PLoS ONE. 9 ,
11 , e113579.
研究成果: 雜誌貢獻 › 文章 › 同行評審
chronic hepatitis
100%
Antirheumatic Agent
90%
Hepatitis Viruses
72%
rheumatoid arthritis
72%
Chronic Hepatitis
61%
Su, F-H. ,
Chang, S. N. ,
Sung, F. C. ,
Su, C-T. ,
Shieh, Y-H. ,
Lin, C. C. &
Yeh, C-C. ,
12月 1 2014 ,
於: Fertility and Sterility. 102 ,
6 ,
p. 1677-1684 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Male Infertility
100%
Hepatitis B
84%
Infertility
40%
Population
34%
Hepatitis B virus
28%
Su, F-H. ,
Chen, M-C. ,
Liu, C. S. ,
Huang, Y. C. ,
Lin, C. C. ,
Sung, F. C. ,
Su, C-T. &
Yeh, C-C. ,
12月 1 2014 ,
於: Journal of Experimental and Clinical Medicine(Taiwan). 6 ,
6 ,
p. 195-199 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
PPAR gamma
100%
Genetic Polymorphisms
94%
Taiwan
89%
Metabolic Syndrome
82%
Odds Ratio
24%
2013
Liu, C. S. ,
Huang, R. J. ,
Sung, F. C. ,
Lin, C. C. &
Yeh, C. C. ,
2013 ,
於: Disease Markers. 34 ,
3 ,
p. 187-197 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Nitric Oxide Synthase Type III
100%
Metabolic Syndrome
80%
Metabolic
71%
Odds Ratio
42%
Introns
42%
Senghore, T. ,
Su, F. H. ,
Lin, Y. S. ,
Chu, F. Y. &
Yeh, C. C. ,
10月 2013 ,
於: Journal of Experimental and Clinical Medicine(Taiwan). 5 ,
5 ,
p. 181-186 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Hepatitis B
100%
Chronic Renal Insufficiency
94%
Hepatitis B virus
75%
Students
72%
Cross-Sectional Studies
67%
Lai, C. Y. ,
Sung, F. C. ,
Hsieh, L. L. ,
Tang, R. ,
Chiou, H. Y. ,
Wu, F. Y. &
Yeh, C. C. ,
2013 ,
於: Annals of Surgical Oncology. 20 ,
3 SUPPL. ,
p. S599-S606 8 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Genetic Polymorphisms
100%
Fluorouracil
91%
ErbB Receptors
90%
Colorectal Neoplasms
75%
Drug Therapy
56%